• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Intrauterine Contraceptive Devices Companies

    ID: MRFR/HC/6977-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Intrauterine Contraceptive Devices (IUCDs) companies specialize in the development and manufacturing of contraceptive devices designed to be inserted into the uterus to prevent pregnancy. These companies play a crucial role in providing women with effective, long-term contraceptive options. IUCDs, also known as intrauterine devices (IUDs), are T-shaped devices typically made of plastic or metal and may contain hormonal or non-hormonal elements.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Intrauterine Contraceptive Devices Market Research Report-Forecast to 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Intrauterine Contraceptive Devices Market

    Intrauterine Contraceptive Devices CompaniesLatest Intrauterine Contraceptive Devices Companies Update


    • May 2023: Bayer launched heavy menstrual bleeding (HMB), an underdiscussed and underdiagnosed condition, to the attention of the nation by promoting Mirena® (levonorgestrel-releasing intrauterine system) 52 mg, an FDA-approved intrauterine device (IUD) that can be used to treat heavy periods in women who choose IUDs for birth control for up to five years. Bayer's new multi-channel campaign, Seeing Red, is designed to increase public consciousness regarding HMB and a prospective therapeutic alternative. Seeing Red advocates for women throughout the United States to discuss their heavier periods with their healthcare provider in order to determine whether Mirena may be a suitable option. Many women are ignorant that HMB is a medical condition or that treatment options may be available, despite the condition's prevalence and impact. Some have been misinformed or mistakenly believe that heavy periods are a typical occurrence.



    • Society for Family Health (SFH), Population Services International (PSI), and Medicines360 jointly declared the introduction of Avibela (levonorgestrel-releasing intrauterine system) 52 mg in Nigeria. Historically, Nigerian women and girls have had limited access to contraceptive methods. The introduction of Avibela expands the reproductive health options available to women and girls. This signifies the introduction of Medicines360's hormonal intrauterine device (IUD) in its fourth African country, following Kenya, Madagascar, and Zambia. They are able to increase access to a high-quality, cost-effective hormonal IUD through their partnership with PSI and SFH at a time when modern contraception is more crucial than ever. Vital on-the-ground services, such as provider training, quality assurance, product awareness, and local capacity building initiatives, are rendered possible by their partners in order to guarantee sustainable accessibility to the hormonal intrauterine device.


    List of Intrauterine Contraceptive Devices Companies in the market

    • Bayer AG

    • Eurogine, S.L.

    • The Cooper Companies, Inc.

    • Pfizer Inc.

    • HLL Lifecare Limited

    • OCON Healthcare

    • SMB Corporation

    • Egemen International

    • Meril Life Sciences Pvt. Ltd.

    • Mona Lisa N.V.

    • Prosan International B.V.

    • Pregna International Limited